Medicus Pharma Ltd (TSE:MDCX) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Medicus Pharma Ltd. has successfully completed the initial phase of its private placement, issuing US$5.17 million in 10% unsecured convertible notes, with potential for an additional amount up to US$10 million. These notes, maturing in 2025, offer semi-annual interest payments and can convert into common shares under specific conditions, such as an initial public offering in the United States or a change of company control. Investors also have the option to convert the notes at a set price or have them repurchased by the company under certain circumstances.
For further insights into TSE:MDCX stock, check out TipRanks’ Stock Analysis page.
